These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 6292982

  • 1. Discriminative stimulus properties of narcotic and non-narcotic drugs in rats trained to discriminate opiate kappa-receptor agonists.
    Shearman GT, Herz A.
    Psychopharmacology (Berl); 1982; 78(1):63-6. PubMed ID: 6292982
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH, Code RA.
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 4. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ, Cook CD.
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [Abstract] [Full Text] [Related]

  • 6. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT, Herz A.
    Eur J Pharmacol; 1982 Aug 27; 82(3-4):167-72. PubMed ID: 6290235
    [Abstract] [Full Text] [Related]

  • 7. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE, Holtzman SG.
    J Pharmacol Exp Ther; 1986 May 27; 237(2):437-44. PubMed ID: 3009783
    [Abstract] [Full Text] [Related]

  • 8. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
    Holtzman SG.
    J Pharmacol Exp Ther; 1989 Mar 27; 248(3):1054-62. PubMed ID: 2539453
    [Abstract] [Full Text] [Related]

  • 9. D-Ala2,D-Leu5-enkephalin generalizes to a discriminative stimulus produced by fentanyl but not ethylketocyclazocine.
    Shearman GT, Herz A.
    Pharmacol Biochem Behav; 1982 Feb 27; 16(2):249-52. PubMed ID: 6280202
    [Abstract] [Full Text] [Related]

  • 10. A kappa opioid effect: increased urination in the rat.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Jan 27; 224(1):89-94. PubMed ID: 6294284
    [Abstract] [Full Text] [Related]

  • 11. Evidence that the discriminative stimulus properties of fentanyl and ethylketocyclazocine are mediated by an interaction with different opiate receptors.
    Shearman GT, Herz A.
    J Pharmacol Exp Ther; 1982 Jun 27; 221(3):735-9. PubMed ID: 6283060
    [No Abstract] [Full Text] [Related]

  • 12. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT, Schulz R, Schiller PW, Herz A.
    Psychopharmacology (Berl); 1985 Jun 27; 85(4):440-3. PubMed ID: 2862651
    [Abstract] [Full Text] [Related]

  • 13. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Slifer BL, Dykstra LA.
    Life Sci; 1987 Jan 26; 40(4):343-9. PubMed ID: 3027481
    [Abstract] [Full Text] [Related]

  • 14. Nitrous oxide generalizes to a discriminative stimulus produced by ethylketocyclazocine but not morphine.
    Hynes MD, Hymson DL.
    Eur J Pharmacol; 1984 Oct 01; 105(1-2):155-9. PubMed ID: 6149142
    [Abstract] [Full Text] [Related]

  • 15. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
    Picker MJ.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1190-8. PubMed ID: 8138931
    [Abstract] [Full Text] [Related]

  • 16. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ, Holtzman SG.
    Eur J Pharmacol; 1980 Nov 07; 68(1):1-10. PubMed ID: 6256182
    [Abstract] [Full Text] [Related]

  • 17. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC, Janssen PA.
    J Pharmacol Exp Ther; 1984 Jul 07; 230(1):193-9. PubMed ID: 6747824
    [Abstract] [Full Text] [Related]

  • 18. Discriminative stimulus properties of bremazocine in the rat.
    Shearman GT, Herz A.
    Neuropharmacology; 1981 Dec 07; 20(12A):1209-13. PubMed ID: 7322297
    [No Abstract] [Full Text] [Related]

  • 19. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct 07; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.
    Picker M, Heise JW, Dykstra LA.
    Pharmacol Biochem Behav; 1987 May 07; 27(1):73-80. PubMed ID: 3615550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.